Publications

Health professionals should be alert to the possibility of Middle East respiratory syndrome (MERS) in unwell travellers returning from the Middle East and obtain a full travel and exposure history.

This document includes an overview of the key elements of the Health Insurance Legislation Amendment (Assignment of Medicare Benefits) Bill 2024 as introduced to Parliament on 29 May 2024. It focuses on simplified billing assignment.

This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 29 April 2024 to 12 May 2024.

An overview of the Private Hospital Sector Financial Health Check.

The Nurse Practitioner Workforce Plan Implementation Advisory Group (IAG) met on 20 May 2024. This document provides a record of the meeting.

This document provides the Australian Government's response to the report on the Independent Capability Review of the Aged Care Quality and Safety Commission (ACQSC). The Government accepts all 32 recommendations.

An interactive monthly planner to plan what activities you will do to meet the physical activity guidelines. You can plan and record your activities and monitor your progress.

An agreement between the Department of Health and Aged Care and the Pharmacy Guild of Australia.

An agreement between the Department of Health & Aged Care and the Pharmaceutical Society of Australia.

This booklet has information about aged care volunteering and the ACVVS for potential and current volunteers, volunteer managers and providers.

This fact sheet details key changes to dispensing medicines under the Eighth Pharmacy Agreement (8CPA). The 8CPA started on 1 July 2024 and will be in place until 30 June 2029.

This fact sheet details how community pharmacy programs work under the Eighth Community Pharmacy Agreement (8CPA). The 8CPA started on 1 July 2024 and will be in place until 30 June 2029.

This infographic shows the number of flu (influenza) vaccinations reported to the Australian Immunisation Register (AIR) during 2021–2024, since 1 March.

These documents contain advice on the Prescribed List (PL) adjusted benefits, resulting from the public benchmarking undertaken by the Independent Health and Aged Care Pricing Authority (IHACPA). The documents outline the November 2023 PL benefits, and the adjusted benefits effective 1 July 2024.

The Australian Government announced the Medical Research Future Fund (MRFF) 3rd 10-year Investment Plan in the 2024–25 Budget. The $6.5 billion investment plan updates and replaces the 2nd 10-year Investment Plan.

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This certification statement, signed by Secretary Blair Comley on 31 May 2024, certifies that the National Tobacco and E-cigarette campaign complies with relevant guidelines and policies.

A case study from people who are saving more on their PBS medicines.

This report summarises the feedback received from the new Aged Care Act exposure draft consultation.

This publication contains the presentation slides used for the Digital Transformation Tech Talk held on 21 May 2024. During this webinar, we looked at latest updates on digital transformation for the aged care sector.

This communique announces the appointment of an Independent Reviewer to examine the complexity of the National Registration and Accreditation Scheme.

An update from the Aboriginal and Torres Strait Islander Health Services Data Advisory Group (HS DAG) following their meeting in May 2024. It outlines the group's work across the Indigenous health data space.

These terms of reference outline the scope of the independent review into the complexity of the National Registration and Accreditation Scheme.

This report provides a comprehensive summary of stakeholder consultation findings for Stage 1 of the National Nursing Workforce Strategy. It offers a summary of stakeholder consultation, environment scans and literature reviews and summarises the common issues and themes.

This user guide supports prescribers in all healthcare settings to adopt active ingredient prescribing.